Munch-a-Biotech Today Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Munch-a-Biotech Today

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: sim1 who wrote (2841)	4/19/2010 9:09:14 AM
From: tuck	Read Replies (1) of 3158

>>Javelin Pharmaceuticals Announces Termination of Merger Agreement with Myriad Pharmaceuticals, Cancels Special Meeting of Stockholders Press Release Source: Javelin Pharmaceuticals, Inc. On Monday April 19, 2010, 8:50 am CAMBRIDGE, Mass.--(BUSINESS WIRE)--Javelin Pharmaceuticals, Inc. ("Javelin") (NYSE -- Amex: JAV) today announced that it had terminated its merger agreement with Myriad Pharmaceuticals, Inc. ("MPI") (Nasdaq: MYRX - News). As a result of the termination of the merger agreement, Javelin’s Special Meeting of Stockholders to vote on the adoption and approval of the merger agreement with MPI scheduled for April 22, 2010 has been canceled.<< snip Not much color on the reason for this. Cheers, Tuck

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next